dihydroresveratrol has been researched along with allyl isothiocyanate in 1 studies
| Studies (dihydroresveratrol) | Trials (dihydroresveratrol) | Recent Studies (post-2010) (dihydroresveratrol) | Studies (allyl isothiocyanate) | Trials (allyl isothiocyanate) | Recent Studies (post-2010) (allyl isothiocyanate) |
|---|---|---|---|---|---|
| 35 | 2 | 27 | 500 | 7 | 313 |
| Protein | Taxonomy | dihydroresveratrol (IC50) | allyl isothiocyanate (IC50) |
|---|---|---|---|
| Macrophage migration inhibitory factor | Homo sapiens (human) | 0.675 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Y; Kogure, Y; Mabuchi, M; Nakao, S; Noguchi, K; Shimizu, T; Tanaka, A; Wang, S | 1 |
1 other study(ies) available for dihydroresveratrol and allyl isothiocyanate
| Article | Year |
|---|---|
Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
Topics: Analgesics; Animals; Calcium Channels; Ganglia, Spinal; HEK293 Cells; Humans; Inhibitory Concentration 50; Nerve Tissue Proteins; Pain; Patch-Clamp Techniques; Rats; Resveratrol; Stilbenes; Transient Receptor Potential Channels; TRPA1 Cation Channel | 2017 |